Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Jac-Antimicrobial Resistance|March 20, 2023
Re-evaluation of cefepime or piperacillin/tazobactam to decrease use of carbapenems in ESBL-producing Enterobacterales urinary tract infections (REDUCE-UTI)Alexander C Branton, Catherine H Vu, Veena Venugopalan, et al.
Therapeutic Drug Monitoring|November 29, 2023
A Randomized Clinical Trial of Bayesian-Guided Beta-Lactam Infusion Strategy and Associated Bacterial Resistance and Clinical Outcomes in Patients With Severe PneumoniaNicole F Maranchick, Cesar Trillo-Alvarez, Vidhu Kariyawasam, et al.
American Journal of Pharmaceutical Education|June 19, 2023
Exploring Trends in Social Vulnerability for Pharmacy Students at a Large Public UniversityJohn M Allen, Teresa M Cavanaugh, Tyisha Hathorn, et al.
Antimicrobial Agents and Chemotherapy|July 1, 2020
Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial DosingMohammad H Al-Shaer, Michael N Neely, Jiajun Liu, et al.
Jac-Antimicrobial Resistance|January 23, 2024
Association of piperacillin and vancomycin exposure on acute kidney injury during combination therapyVeena Venugopalan, Nicole Maranchick, Devorah Hanai, et al.
Antimicrobial Agents and Chemotherapy|October 18, 2021
Applying Cefepime Population Pharmacokinetics to Critically Ill Patients Receiving Continuous Renal Replacement TherapyMohammad H Al-Shaer, Kelly Maguigan, Jennifer Ashton, et al.
Antimicrobial Agents and Chemotherapy|December 13, 2021
Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population PharmacokineticsMohammad H Alshaer, Sylvain Goutelle, Barbara A Santevecchi, et al.
American Journal of Infection Control|October 6, 2024
Development and implementation of learning collaboratives for infection prevention and control education in long-term care facilitiesCindy Prins, Mishal Khan, Nicole M Marlow, et al.
Pharmacotherapy|November 19, 2022
Use of therapeutic drug monitoring to characterize cefepime-related neurotoxicityVeena Venugopalan, Danielle Casaus, Leonie Kainz, et al.
Open Forum Infectious Diseases|March 13, 2020
Real-world Multicenter Analysis of Clinical Outcomes and Safety of Meropenem-Vaborbactam in Patients Treated for Serious Gram-Negative Bacterial InfectionsSara Alosaimy, Sarah C J Jorgensen, Abdalhamid M Lagnf, et al.
Pageof 5